B
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD
NYSE: BHVN (Biohaven Ltd.)
最近更新时间: 13小时之前36.26
0.92 (2.60%)
| 前收盘价格 | 35.34 |
| 收盘价格 | 34.85 |
| 成交量 | 2,580,291 |
| 平均成交量 (3个月) | 1,079,892 |
| 市值 | 3,666,683,648 |
| 股市价格/股市净资产 (P/B) | 11.75 |
| 52周波幅 | |
| 利润日期 | 3 Aug 2023 - 7 Aug 2023 |
| 稀释每股收益 (EPS TTM) | -9.37 |
| 总债务/股东权益 (D/E MRQ) | 8.01% |
| 流动比率 (MRQ) | 2.89 |
| 营业现金流 (OCF TTM) | -526.59 M |
| 杠杆自由现金流 (LFCF TTM) | -397.26 M |
| 资产报酬率 (ROA TTM) | -118.79% |
| 股东权益报酬率 (ROE TTM) | -265.45% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Biohaven Ltd. | 看涨 | 看涨 |
AIStockmoo 评分
2.5
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 2.50 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.16% |
| 机构持股比例 | 87.14% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suvretta Capital Management, Llc | 30 Sep 2024 | 5,199,219 |
| Bellevue Group Ag | 30 Sep 2024 | 2,040,853 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 76.00 (Piper Sandler, 109.60%) | 购买 |
| 中 | 62.00 (70.99%) | |
| 低 | 59.00 (HC Wainwright & Co., 62.71%) | 购买 |
| 平均值 | 65.22 (79.87%) | |
| 总计 | 9 购买 | |
| 平均价格@调整类型 | 45.42 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Dec 2024 | 59.00 (62.71%) | 购买 | 39.12 |
| 26 Nov 2024 | 59.00 (62.71%) | 购买 | 47.28 | |
| RBC Capital | 04 Dec 2024 | 61.00 (68.23%) | 购买 | 46.06 |
| 25 Nov 2024 | 58.00 (59.96%) | 购买 | 45.23 | |
| TD Cowen | 13 Nov 2024 | 75.00 (106.84%) | 购买 | 49.04 |
| JP Morgan | 03 Oct 2024 | 68.00 (87.53%) | 购买 | 46.65 |
| B of A Securities | 24 Sep 2024 | 62.00 (70.99%) | 购买 | 45.04 |
| Bernstein | 24 Sep 2024 | 66.00 (82.02%) | 购买 | 45.04 |
| Baird | 23 Sep 2024 | 60.00 (65.47%) | 购买 | 45.94 |
| Leerink Partners | 23 Sep 2024 | 60.00 (65.47%) | 购买 | 45.94 |
| Piper Sandler | 23 Sep 2024 | 76.00 (109.60%) | 购买 | 45.94 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合